These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8760650)

  • 1. [Activated protein C resistance and mutation of coagulation factor V].
    Samama MM
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
    Spannagl M; Schramm W
    Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new hereditary cause of portal vein thrombosis: the abnormal resistance to activated protein C by the Arg 506-->Gln mutation of the gene of factor V].
    Levoir D; Aubertin JM; Alhenc-Gelas M; Bloch F; Becheur H; Petite JP
    Gastroenterol Clin Biol; 1995; 19(8-9):729-31. PubMed ID: 8522125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients.
    Montes MA; Fox EA; Longtine JA; Dorfman DM
    Arch Pathol Lab Med; 1998 Apr; 122(4):325-9. PubMed ID: 9648899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis.
    Thorarensen O; Ryan S; Hunter J; Younkin DP
    Ann Neurol; 1997 Sep; 42(3):372-5. PubMed ID: 9307261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C resistance: the commonest hereditary hypercoagulation disorder.
    Sulaiman-Shoab S
    Br J Surg; 1998 Aug; 85(8):1161. PubMed ID: 9718029
    [No Abstract]   [Full Text] [Related]  

  • 11. [Factor V Leiden and activated protein C resistance].
    Cauchie P; Hilbert P
    Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C resistance: the commonest hereditary hypercoagulation disorder.
    Khogali I; Summerfield GP; Mudawi A
    Br J Surg; 1998 Aug; 85(8):1160; author reply 1161. PubMed ID: 9718028
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular genetics of thrombophilia: factor V gene mutation causing resistance to activated protein C as a basis of the hypercoagulable state.
    Dahlbäck B
    J Lab Clin Med; 1995 May; 125(5):566-71. PubMed ID: 7738422
    [No Abstract]   [Full Text] [Related]  

  • 14. [The significance of APC resistance (activated protein C) for clinical practice].
    Lämmle B; Demarmels Biasiutti F; Wuillemin WA; Stucki B; Furlan M
    Praxis (Bern 1994); 1997 Jan; 86(5):154-61. PubMed ID: 9064734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation factor V and thrombophilia: background and mechanisms.
    Segers K; Dahlbäck B; Nicolaes GA
    Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for resistance to activated protein C factor V R506Q.
    Mack R; Albanese E; Fernandes H
    Arch Pathol Lab Med; 1998 Dec; 122(12):1046. PubMed ID: 9870848
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
    Dahlbäck B
    Rev Invest Clin; 1997 May; 49 Suppl 1():3-5. PubMed ID: 9291738
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor V Leiden mutation presenting as repeated massive GI hemorrhages secondary to venous thrombosis.
    Lynch JP; Rosato EF; Kochman ML
    Am J Gastroenterol; 1997 Dec; 92(12):2310-1. PubMed ID: 9399782
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance to activated protein C. The most common cause of familial thrombophilia].
    Larsen TB; Ravn HB; Lassen JF; Lund ED; Brandslund I
    Ugeskr Laeger; 1996 Nov; 158(46):6584-8. PubMed ID: 8966822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma resistance to activated protein C: an important link between venous thromboembolism and combined oral contraceptives--a short review.
    Jespersen J
    Eur J Contracept Reprod Health Care; 1996; 1(1):3-11. PubMed ID: 9678132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.